Skip to main content
. 2012 Mar 12;6:153–164. doi: 10.4137/CMO.S7327

Table 2.

Response according to treatment arms of the randomized phase III trial.

TEMSR 175/75
n = 54
TEMSR 175/25
n = 54
Invest choice
n = 54
Overall response rate 22% 6% 2%
95% CI 11–13 0–12 0–5
P-value 0.0019 0.6179
Complete remissions, n 1 0 1
Partial remissions, n 11 3 0
Response median (95% CI), in month 7.1 (4.1–NA) 3.6 (3.2–10.6) NA